The local manufacturing facility will support the growing momentum behind mRNA-based medicines and vaccines beyond COVID-19.

Catalyst Pharmaceuticals reported adjusted earnings of 40 cents per share on $98.4 million in first-quarter sales. In ...

AI models and machine learning algorithms are becoming core to biotech discoveries and their drug development processes. As a ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The biotechnology sector is renowned for its potential to ...

Listen to this article CEL-SCI Corporation, the Vienna, Virginia-based biotechnology company with operations in Baltimore, ...

The news of the licensee deal comes on the heels of the DEA's move to reschedule marijuana, one source of cannabinoids, as a ...

Many are highly innovative corporations that develop breakthrough medicines for rare and hard-to-treat diseases. Even when ...

CEO Rusty Williams, M.D., Ph.D., said in an interview with Fierce Biotech that the company was on the precipice of securing fresh capital to enter the clinic when an unnamed top investor backed out, ...

Clinical-stage, pre-revenue pharmaceutical company Edgewise Therapeutics Inc. has appointed biotechnology industry veteran ...

USDA, EPA and FDA announced a joint plan Wednesday that lays out steps the agencies are taking to further streamline the regulation of genetically modified plants, animals and microorganisms.

The latest offer includes new contingent value rights. Shares in D.C. biotech Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shot up more than 13% on Tuesday after it said it is considering a sweetened ...